- Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
-
Narayan V, Mamtani R, Keefe S, Guzzo T, Malkowicz , Vaughn DJ
- KMID: 2344082
- Cancer Res Treat.
- 2016 Jul;48(3):1084-1091.
- doi: 10.4143/crt.2015.405
PURPOSE: We sought to investigate the safety and efficacy of gemcitabine, cisplatin, and lapatinib (GCL) as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) planned for radical cystectomy. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
